Jefferies Waiting On Upturn In Life Science Leasing For BioMed

BioMed Realty Trust, Inc.

is having coverage initiated with a Hold rating and $19 price target by Jefferies & Co. The reason for the Hold is as follows: "We are positive on BMR's exposure to the secular growth of the life science industry and are relatively optimistic about its considerable lease-up potential. However, we would prefer to see evidence of an improvement in leasing velocity before becoming more constructive on the name." BioMed Realty Trust, Inc. closed yesterday at $19.16.